http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12518841

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, U.S. Gov't, P.H.S.|Review
endingPage 54
issn 0920-1211
issueIdentifier 1-2
pageRange 41-54
publicationName Epilepsy Research
startingPage 41
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e423e98d115894f5b30465dcb1113e0c
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_321686f49bd547914ca540643434c305
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3fe39cf314b8b5f4604c82a0d332c472
bibliographicCitation Holmes GL. The interface of preclinical evaluation with clinical testing of antiepileptic drugs: role of pharmacogenomics and pharmacogenetics. Epilepsy Res. 2002 Jun;50(1-2):41–54. doi: 10.1016/s0920-1211(02)00067-0. PMID: 12151116.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5ae10ba21caf850f9641291b0c17c13
date 200206
identifier https://doi.org/10.1016/s0920-1211%2802%2900067-0
https://pubmed.ncbi.nlm.nih.gov/12151116
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
https://portal.issn.org/resource/ISSN/0920-1211
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title The interface of preclinical evaluation with clinical testing of antiepileptic drugs: role of pharmacogenomics and pharmacogenetics
discusses http://id.nlm.nih.gov/mesh/M0001382
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D010597
http://id.nlm.nih.gov/mesh/D004827Q000188
http://id.nlm.nih.gov/mesh/D004827Q000235
http://id.nlm.nih.gov/mesh/D023281
http://id.nlm.nih.gov/mesh/D000927Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011110Q000235
http://id.nlm.nih.gov/mesh/D004353
http://id.nlm.nih.gov/mesh/D000927Q000633
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191

Total number of triples: 35.